White label ELPA - ClinicalTrials.eu

Study on Ruxolitinib and Drug Combination for Critically Ill Adults with Acquired Hemophagocytic Syndrome

Not recruiting

2 1 1 1
Investigated Drugs:
Study Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension

Not recruiting

3 1 1
Investigated Diseases:
- Ocular hypertension
- Open angle glaucoma
Investigated Drugs:
- Bimatoprost
Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Not recruiting

1 1 1 1
Investigated Drugs:
- 2-Amino-6-Fluoro-N-(5-Fluoro-4-(1-Methyl-1H-Imidazol-5-Yl)Pyridin-3-Yl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
- Cemiplimab
Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Abemaciclib
Study of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

Not recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
- Adagrasib
+3
Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Not recruiting

2 1 1
Investigated Diseases:
- Type 1 diabetes mellitus
+7
Study of Tirzepatide and Placebo for People with Overweight or Obesity and Chronic Kidney Disease, with or without Type 2 Diabetes

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Iohexol
- Tirzepatide
Study on the Effect of Famotidine in Reducing P-selectin Levels in Children with Sickle Cell Disease

Not recruiting

3 1 1 1
Investigated Drugs:
- Famotidine
Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies